TechNavio today launched its report Global Biopsy Devices Market 2010“2014 based on an in-depth study covering the Americas, the EMEA and APAC regions. The report aids decision makers™ understanding of the present and future landscape of the Global Biopsy Devices market.
Commenting on the report, an analyst from TechNavio™s Healthcare team said, As a result of the high initial cost of biopsy devices, healthcare institutions with lower budgets prefer purchasing reprocessed biopsy devices. This trend is increasing in healthcare institutions in low-economy countries. Further, there are several global and regional bodies that certify reprocessed biopsy devices, which in turn influence the purchase of reprocessed biopsy devices. This trend is expected to have a medium impact on the market.
According to the report, advancements in biopsy technologies and the widespread acceptance of minimally invasive surgeries are driving the market. Moreover, the high adoption rates of new breast biopsy products, including VAB, core needle biopsy (CNB), and fine needle aspiration (FNA) devices will drive the market significantly. These advancements in the market will boost its revenue by the end of the forecast period.
The contents of this report are based on research conducted on an objective combination of primary and secondary scores, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit https://www.technavio.com/content/global-biopsy-devices-market-2010-2014
Follow us on Twitter @Technavio
TechNavio Announces the Publication of its Report “ Global Biopsy Devices Market 2010“2014
